MBTPS1 and inflammatory bowel disease: Although molecular mechanisms involved in the pathogenesis of IBD are still poorly understood, different studies have shown that the SphK/S1P pathway is activated in human IBD colons and in rodent models of IBD and its inhibition may prove to be a valuable therapeutic target [5,6,19].